Variant DNA sequences flanking the human insulin gene were found in the Danish population using restriction endonucleases (restriction fragment length polymorphism). The frequencies of these DNA sequences were determined in 47 non-insulin-dependent diabetics and 93 control individuals. We report an association between a restriction fragment length polymorphism of the insulin gene and NIDDM. DIABETES 31:275-277, March 1982. D iabetes mellitus (DM), a syndrome characterized by insufficient insulin secretion, hyperglycemia, and propensity to develop universal microangiopathy, neuropathy, and atherosclerosis, is a common condition affecting 1-2% of Caucasian populations. 1 DM is common in all ethnic groups, its prevalence increases with age and more than 5% of individuals of more than 65 yr of age have DM. Two major types of DM exist: insulin-dependent diabetes mellitus (IDDM) comprises 10-15% of all DM and is characterized by a selective beta-cell destruction, very low if any insulin secretion, absolute requirement for exogenous insulin, low age of onset (although cases do occur in all ages), and high prevalence of autoantibodies directed against antigenic determinants of the beta-cells. 2 Recently, IDDM was shown to be strongly associated with two alleles (HLA-DR3 and DR4) of the HLA-D/DR locus on chromosome 6.
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iabetes mellitus (DM), a syndrome characterized by insufficient insulin secretion, hyperglycemia, and propensity to develop universal microangiopathy, neuropathy, and atherosclerosis, is a common condition affecting 1-2% of Caucasian populations. 1 DM is common in all ethnic groups, its prevalence increases with age and more than 5% of individuals of more than 65 yr of age have DM. Two major types of DM exist: insulin-dependent diabetes mellitus (IDDM) comprises 10-15% of all DM and is characterized by a selective beta-cell destruction, very low if any insulin secretion, absolute requirement for exogenous insulin, low age of onset (although cases do occur in all ages), and high prevalence of autoantibodies directed against antigenic determinants of the beta-cells. 2 Recently, IDDM was shown to be strongly associated with two alleles (HLA-DR3 and DR4) of the HLA-D/DR locus on chromosome 6. 3 In non-insulin-dependent diabetes mellitus, which comprises 85-90% of all DM, insulin secretion is preserved, and such cases can be treated with dietary changes often combined with oral antidiabetic drugs. NIDDM is probably a rather heterogenous condition, but age of onset is relatively late in life.
Studies of identical twins 4 have shown the hereditary component in NIDDM to be stronger than in IDDM, but no proven genetic markers have been associated with the occurrence of NIDDM. One possible cause for NIDDM is the presence of an abnormal insulin molecule. Structurally abnormal insulins have been found in two families with hyperproinsulinemia, 5 -6 and abnormal insulin in one individual with diabetes mellitus, 7 but their occurrence appears to be rare. Alternatively, abnormal regulatory sequences linked to the insulin gene could occur in NIDDM individuals and thus cause the glucose intolerance or hyperglycemia. Variant DNA sequences within and flanking the insulin gene have been detected using restriction endonucleases (restriction fragment length polymorphism).
8 " 10 We report here the association between restriction fragment length polymorphism of the insulin gene and NIDDM.
MATERIALS AND METHODS
DNA isolation. DNA (100-300 /xg) was isolated from nucleated blood cells obtained from 10 ml venous whole blood by the method of Kunkef et al. 11 Citrate buffer (ADCformula A) was used in place of heparin to prevent coagulation in the blood samples. Identification of DNA sequences containing the insulin gene. DNA (1 -3 /xg) was digested in a volume of 100 fx\ for 15-20 h with 10 U of the restriction endonuclease Bgl I (Boehringer Mannheim) according to the manufacturers' specifications. Nuclease-free bovine serum albumin (Bethesda Research Labs, 100 /xg/ml) was included in the digestions to stabilize the enzyme. Preparation of the samples for electrophoresis and electrophoresis on 1 % agarose gels was performed as described previously.
12 DNA was transferred from the gel to nitrocellulose filters (Schleicher and Schull) by the method of Southern 13 and then hybridized with 32 p-human insulin probe. The probe was prepared from a Hinc Il-Bgl I fragment of the human insulin genomic clone XHI-1, 10 which was a gift from Drs. Graeme I. Bell and William J. Rutter. The insert was labeled by nick translation 14 to specific activities of 2-4 x 10 8 cpm//ng DNA. Filters were hybridized and washed as described previously. 12 Washed filters were exposed to X-Omat RP film with a Dupont lightning plus intensifying screen at -70°C for 3-10 days.
RESTRICTION FRAGMENT LENGTH POLYMORPHISM IN THE INSULIN GENE

RESULTS
DNA was isolated from nucleated blood cells, digested with restriction endonucleases, separated by size on agarose gels, transferred to nitrocellulose filters, and hybridized with a 32 p-labeled human insulin DNA probe as described in MATERIALS AND METHODS. Figure 1 shows a representative autoradiogram of the resulting DNA sequences after digestion with the restriction enzyme Bgl I and hybridization with insulin probe. Two distinct DNA size classes were evident. One class was of approximately 3.0 kilobases (kb) and varied in size from 2.7 to 3.2 kb. The second class was at approximately 4.8 kb and ranged from 4.3 to 5.0 kb. We have designated the larger size class the U allele (upper electrophoretic type) and the smaller size class the L allele (lower electrophoretic type). The genotypes of different individuals were denoted UU (homozygous upper), UL heterozygous upper-lower) and LL (homozygous lower). The ability to resolve alleles of the insulin gene permitted an analysis of their segregation in families. Segregation of the alleles in one family, spanning three generations, is shown in Figure 2 . This segregation of alleles follows Mendelian distribution. In addition, no nonparental genotypes were detected.
The frequencies of the UU, UL, and LL genotypes were also analyzed in 47 NIDDM and 93 control, nonrelated individuals and are shown in Table 1 . The control individuals were composed of 2 groups: 37 individuals had IDDM and 56 were blood donors randomly selected from a blood bank (University Hospital, Rigshospitalet, Copenhagen). A significant difference was observed between the frequency of the alleles in NIDDM versus IDDM groups (P -0.026, see Table  1 ). The frequency of the UU genotype was 6.3-fold higher in the NIDDM group. The frequency of UU in NIDDM individuals was 2.4-fold higher compared with the second control group, which was composed of blood bank donors. Unfortunately, the donors were untested for glucose intolerance and thus it is unknown whether any of the 4 UU individuals found were actually diabetic. Consent could not be ob- tained to test these individuals for glucose intolerance. Nevertheless, the increased frequencies of the UU genotype in NIDDM versus both control groups strongly suggest that there is an association between this genotype and NIDDM. No differences in age, age at onset, and duration of NIDDM were found between individuals of the UU, UL, and LL genotypes. The UU and UL genotypes, however, seemed to be associated with high prevalence of macroangiopathy (i.e., myocardial infarction, stroke, and atherosclerosis of vessels of the lower extremities) when compared with patients with NIDDM and the LL genotype (unpublished results). All three groups were predominantly obese (i.e., body weight larger than 120% of ideal).
DISCUSSION
Three reports dealing with the same restriction fragment length polymorphism of the insulin gene have been published.
10>15
- 16 It was established that the polymorphism results from DNA insertions or deletions located approximately 500 nucleotides from the 5' end of the insulin gene. The U alleles we have reported would thus result from large DNA insertion sequences (1600-2300 nucleotides) and the L alleles from small DNA insertions or deletions (0-500 nucleotides). The high degree of size variation between sequences suggests that this region of chromosome 11 12 -17 -18 may be a recombinatorial "hot spot". Though we did not detect recombinant sequences in the families tested, the study of larger numbers of families may resolve this issue.
We find the distribution of U and L alleles to be different in NIDDM compared with IDDM individuals. The largest single difference was seen in the homozygous UU genotype. Thus, these results can be interpreted as either an increased frequency of the UU genotype in NIDDM versus IDDM or a decreased frequency in IDDM versus NIDDM individuals. The finding that the U allele is associated with elevated HbA 1c levels in nondiabetic individuals (unpublished results), supports the former hypothesis.
Significant differences were not detected in the frequencies of alleles between blood donors and NIDDM or blood donors and IDDM individuals. These results are not unexpected, since the blood donors were not an ideal normal control. An ideal control group should consist of individuals as old as possible, i.e., at least 60 yr of age and shown to have normal glucose regulation over a period of many years. We are currently determining the frequency of the alleles in such a control group. While these experiments were in progress, two studies investigating restriction fragment length polymorphism in diabetics have been published. 15 ' 16 In one report, 15 no association was found between the DNA insertions and NIDDM. In the other report, 16 a statistical association between the U allele (UU + UL) and NIDDM was demonstrated when compared with controls. The reasons for these discrepancies are uncertain, but might be due to differences in the populations studied. The patient materials we studied were very carefully selected as being IDDM and NIDDM patients, respectively. In addition, patients and blood bank donors were all of Danish ancestry.
The finding of the 6.3-fold increase of the UU genotype in NIDDM individuals compared with the IDDM controls suggests that the UU genotype is a genetic marker of a form of NIDDM. This observation further supports that NIDDM and IDDM are different disease entities and suggests heterogeneity within NIDDM. The possibility that the UU genotype produces a clinically distinct form of NIDDM should be studied in greater detail.
